GW Pharmaceuticals
14stories
GW Pharmaceuticals · page 2
- Markets & Stocks
German Cannabis Stocks Jump on Passage of Draft Adult-Use Bill, More from Jazz Pharma & Ananda Developments
German Stocks Spike on Passage of Draft Law [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”SBX.DE” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Synbiotic SE (SBX) Yesterday, the German federal cabinet officially passed the draft law which would seek to implement Pillar 1 of the country’s ambitious adult-use cannabis legalisation strategy.
- Pharmaceutical
Has GW Pharmaceuticals – Now Jazz Pharmaceuticals – Knee-Capped The CBD Industry?
WITH the fast-growing CBD sector tied up in a regulatory quagmire hundreds of transatlantic industry players face an uncertain future.
